PF-06767832   Click here for help

GtoPdb Ligand ID: 9228

Synonyms: PF06767832
Compound class: Synthetic organic
Comment: PF-06767832 (compound 38) is an orally bioavailable, positive allosteric modulator (PAM) selective for the M1 muscarinic acetylcholine receptor (CHRM1) [2]. It is one of the compounds claimed in patent WO2016009297 [1]. M1 receptor PAMs are being designed for their potential to provide novel therapies for the treatment of M1-mediated diseases and disorders such as Alzheimer's disease.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 112.58
Molecular weight 409.15
XLogP 3.05
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC1COCCC1NC(=O)c1ncc(c(c1)Cc1ccc(cc1)c1cscn1)C
Isomeric SMILES O[C@H]1COCC[C@@H]1NC(=O)c1ncc(c(c1)Cc1ccc(cc1)c1cscn1)C
InChI InChI=1S/C22H23N3O3S/c1-14-10-23-19(22(27)25-18-6-7-28-11-21(18)26)9-17(14)8-15-2-4-16(5-3-15)20-12-29-13-24-20/h2-5,9-10,12-13,18,21,26H,6-8,11H2,1H3,(H,25,27)/t18-,21-/m0/s1
InChI Key VVZZHFMLRHJXTO-RXVVDRJESA-N
No information available.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
In relation to Alzheimer's disease, stimulation of the M1 receptor has been shown to increase formation of the neuroprotective soluble amyloid precursor protein alpha (sAPPa; a proteolyte of APP cleavage by α-secretase), and in so doing, prevents the formation of the Αβ peptide [3]. However, despite not activating the M2 or M3 receptors, in vivo testing in dogs reveals that positive allosteric modulation of M1 causes the gastrointestinal and cardiovascular side-effects (cholinergic liabilities) , that were originally attributed to M2 and M3 receptor activation [2].